{"name":"Transgene","slug":"transgene","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPcjRmTEc4cXdyYkF3SWgyWllJeTF5SGVJbzE2dE5yQTFTY0lpbjkzdEZOaGFUVk4yc3BDTDhsNEtkS1ZoRHowSmtpR252UDlKbUQtNERHd1Z2aFZOa3g1eFNYOVZQa2l0MGdzeFR0a1lPb0wwVzZVclc2SG95cXh5M3hiYjNsa0M3LVEzU185Z2NGeUhVZVF6ZUFrVkJuZFROOG5DUngzSW9HOTBoNW130gG2AUFVX3lxTE1OeGFURVRvMF9lVkJIdDJYdlRCZE5jdXdJQ1hxbEh5MUxVRjJLc3VoWE1Fd201WUQ5SmZCSjVnN1lDSm0zcGhFck5KbzFhTjBwaVYwM3lvMGFWYzBQQnc4NER0UVEyaG42V3BFNkVtRFA0Vkh4TlMxYjcwNlI3OF85ODNqUzM0TE9qVTBtdjV3T1BQem5NQVhWNFNxYzlJeE9ETnV5V3FsQmozNW12MHFMc25qeVdn?oc=5","date":"2026-04-08","type":"pipeline","source":"Indian Pharma Post","summary":"Transgene and NEC join forces to advance personalized cancer vaccine - Indian Pharma Post","headline":"Transgene and NEC join forces to advance personalized cancer vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBrVk5RY2c1S3hDeUc4TjZEUjM0bnJPR0lqR09yQWFETWdqb05OMHo0Uy15NTZJdXdUcUdybHE2SEZ0QVAtbnh0QWdQX1ZTV2hRSnZn?oc=5","date":"2026-04-03","type":"deal","source":"FirstWord Pharma","summary":"Transgene licenses NEC's AI-enabled neoantigen prediction tech - FirstWord Pharma","headline":"Transgene licenses NEC's AI-enabled neoantigen prediction tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNVko2NlpRMG4wUDZtSktVZm1RUmprUTVlYXJVeXdJbnpDdGxNSkhLNVFrcTM4UXhHYTltS0Fhd0RrRkpwQ3dOWXhkMk5POWI5Y05yTFV5LWxPY1V1ckdGelcwVjVNd1BmaUxfU2w5QzR2V2cwR3NaUGZFZ0Rwa3lpTi1USHVDT0pwY28xcm0wdEJMSThW?oc=5","date":"2026-04-03","type":"deal","source":"The Pharma Letter","summary":"Transgene and NEC Bio enter license agreement - The Pharma Letter","headline":"Transgene and NEC Bio enter license agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPbXg0UlQ0VjY0UXRQRXVMaHQ3STN1ZnY5Qkh5Rjhxel81TWhfSS1uMFd3UmZJS1I4WWxHR1IyZ2dZNldvaFdhRjlCVVgzSkpoWWJ4MzU5R0c3SFhDSmFVYVY4WXdJMUJScl81cU9UODBzQkJtbG92eDRJU0ZXM29PVDBhd2VOWEZtZWpsREZvYU0wSlFxTnFyUWRYZ19yVGktdGxERDNiV2VYMmxseFZ1aTFWZXpPLW92dW12NUpLZnlyeWtQQlU5eVJjUUFyd010eDBnRUh3?oc=5","date":"2026-02-12","type":"pipeline","source":"European Pharmaceutical Review","summary":"Accelerating consistent, stable cell line development with targeted integration - European Pharmaceutical Review","headline":"Accelerating consistent, stable cell line development with targeted integration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA4MEFLQXJWZ0oxY1lmOUFXeGpJcFV1THdWTkliLWN0MXprMDk3bW1GRTRCakNyTVBsTzhvS1JhdG9fcWZVM09YNDdBNnIxYjVaR2s0ckQwWlRVUXZYbTB3?oc=5","date":"2025-07-01","type":"regulatory","source":"Nature","summary":"Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny - Nature","headline":"Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQdFZraTJyVHJ2YXl0SzJ2V1dFcmkyVmxIT0ZlbjM4bWN4OWFnVW1xSmt1aHI4Yk9Mc1hKdDJ3RGd3cHpic2VaU1hQYzJKaUVTTFpzcUVVRG43Q3RxRlpiS0RKejExUUN1TGlrVG5hNGxYMUo0UVdnc2lxVWx3NklULWZsRHZLSFZOYU9yYnBlWnIzWE9WalpackM3UEJ5VC05elNGTG1DOUVjZkdiRHFzS3BsblJINjNOMFI5TGRwWGFtRlpsN3RlZ1pMLUw4cjBFeTVUMi1jZjNLaDZ4cFJ3d0hNSVg?oc=5","date":"2025-06-03","type":"pipeline","source":"BioPharma APAC","summary":"Transgene and NEC Report Sustained Disease-Free Survival With TG4050 in Head and Neck Cancer at ASCO 2025 - BioPharma APAC","headline":"Transgene and NEC Report Sustained Disease-Free Survival With TG4050 in Head and Neck Cancer at ASCO 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQSDFHN1c2VnViZkMtMmduMHFnLXA1WG81aHhtSm1mN0otdFZzQWlxMnFyRS1TT1B6elhFVmRfSU5UWXA4Y0RjclFpSHdXOTl6M0F5MWVuSGhSbjVmZjJXRTExZDRDalQ0ajV5QzJNRW9ZUVNpNlE5YWl5eUhnTGlwTl9JTmxLVHFvY3hYR2VvM1BNd2xkT1ZObzJwQktLdi1GeFVLbGhJckJwMld3b0h2TjlPVmJ1MzUyVXBwX1VCNTZLQQ?oc=5","date":"2024-11-05","type":"deal","source":"Contract Pharma","summary":"Transgene, ProBioGen Enter License Agreement for AGE1.CR.pIX Suspension Cell Line - Contract Pharma","headline":"Transgene, ProBioGen Enter License Agreement for AGE1.CR.pIX Suspension Cell Line","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNNW5Mb3g5ZWlUdUxoTkJDS3Q0SUhHUjNRYmhhVTVueXlFenA2LXJpYkJhWXJXUklNSEdQdlFMaGZRNDJwRnNiV0I1RTZsMU9Pd0U5YzU0bk16a0ZBVWM1aFJVU1JBYS1ZV1ZsVHFrbmY1bjlHbzdMbGw2M3paQktsR3YzelRXODQ?oc=5","date":"2024-10-15","type":"trial","source":"pharmaphorum","summary":"Transgene cervical cancer shot misses the mark in phase 2 - pharmaphorum","headline":"Transgene cervical cancer shot misses the mark in phase 2","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUUgydUNUdW5kbGUxRWRZdmUtVXpFWHBVaXZFWlR6WnhKaVBaUnF3RlFUb0ctMFItVVhTT3JmSVBHWFl6LTZ3X3RmTnBpLVgzMllnRmNYdkxYdktyQ2JuX2czSDB3UDBlZ0VPX0F2WHVWc3VfLWZ4M1JlYWJqcTA5M3UyYXRONWljY0gyNXNYekNEX3MwWnVjNkZEMzVESXp4dnVnWE00RjdWd0NZY0w5cnNZSWdyNGFzQldESUR6enBEWjJUMTFicQ?oc=5","date":"2024-10-14","type":"trial","source":"Fierce Biotech","summary":"Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis - Fierce Biotech","headline":"Transgene's viral cancer vaccine flunks midphase test—but subgroup signal spurs ongoing analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQVHZSSUd3NmtZdmpZcFhUSTh3N3U2U2hMUE11d0IwMUpnSU05Q3h4bHpGc3dYR1ozRWRaM0dTeDBZdWJWekQtZzRoUlZzc1JfXzc4STZVR05DeGJtUlRvTkQ4RExmVUlzdFRnQ3NhWUpPR2g3S3VCcFdEUU0wbHhyMXkyeFJVcTI1ZVNoX3VFMW9rRmxOMnNTMTJiMzY2ek0wVkpOaEpLbzFNdENGaW01MV80OU1nLXlHMUZiOGY5YnhxTF9tTlcwZ1dQV0dac0Y0VFlOaE8zWHo0YUw4alBZT0V6dExwMWVCVG1NYWR3TGFBY3did0RHUkRQd3lwcUlmVmhJcjVIbHRCZjB5RXVNWk8ydU5VTUp3c3VDc2M3eUxZYUN1VlhmQmFMUkVpaUFnVDE3bDlZc1djZEZmMUlTUg?oc=5","date":"2024-04-11","type":"trial","source":"prnewswire.com","summary":"Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Phase 2 Study in Locally Advanced BCC Subjects - prnewswire.com","headline":"Stamford Pharmaceuticals Inc Announces the First Patient to Be Treated with SP-002 in Combination with Erivedge® in a Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPeWtWek5Gcl9rRVhHYnI0bC0wdUxYVzRsQmVsbzd1ZUd6OThiMTk4UjhSWDBvbU1EWDJEQkdvRmRFcE5wMEplblo0RTBuUTNJQjR2d1p5eExnQUZKNms4S3pselBIT3A3emhNbGlwakkwdVBKcGQtbmpaNERXc3Q0YlR3Z1hQdw?oc=5","date":"2020-05-04","type":"deal","source":"Pharmaceutical Technology","summary":"Vaxxel buys Transgene’s cell line to develop new vaccines - Pharmaceutical Technology","headline":"Vaxxel buys Transgene’s cell line to develop new vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNMC1UOVRGc3lFWGJCUjZXMVNKUUR4TjQwMHpYbkFiVV9RaE9hYXc0dEljZDh4RUVXNXM4VGhLems1SWVsY19oOXF3NzQyc1RNYUdodTVjV084RWtPcWJvUkV6a1RVV0ZWbS1rTUVzRG9nWVNWVWwxNVQ3SHZobnhfSXZEbFllamZyLTdHaVFlUnVtNVpGRFRDTGFIT2xWOVNOZUE?oc=5","date":"2016-10-12","type":"pipeline","source":"BioPharma Dive","summary":"Merck KGaA, Pfizer and Transgene team up on cancer vaccine - BioPharma Dive","headline":"Merck KGaA, Pfizer and Transgene team up on cancer vaccine","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}